Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 23 Show results per page	View Search Criteria \| Help With Results

Last Modified: 4/21/2008


1.		Phase I/II Study of IL-1A/MITO with Ketoconazole for Metastatic Colorectal and Prostate Carcinomas (Summary Last Modified 08/95)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Supportive care, Treatment				Completed				18 and over				NCI				CRB-9202 NCI-T94-0090N, T94-0090

Last Modified: 4/21/2008


2.		Phase I/II Study of IL-1A plus ICE (IFF/CBDCA/VP-16) with Autologous Bone Marrow Transplantation with and without G-CSF in Patients with Metastatic Carcinomas and Lymphomas (Summary Last Modified 03/98)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				18 to 65				NCI				NCI-91-C-0156B NCI-MB-273, NCI-T91-0090N, T91-0090

Last Modified: 4/21/2008


3.		Phase II Study of IL-1A/VP-16 in Relapsed Osteosarcoma (Summary Last Modified 12/95)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				5 to 70				NCI				MDA-P-93003 NCI-T93-0163D, T93-0163

Last Modified: 4/21/2008


4.		Phase II Evaluation of IL-1A, Indomethacin, and VP-16 in Patients with Metastatic Malignant Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care, Treatment				Completed				18 and over				NCI				CRB-9001C NCI-90-C-83C, NCI-T89-0239N, T89-0239

Last Modified: 4/21/2008


5.		Phase II Study of Continuous-Infusion Taxol (TAX) with G-CSF in Patients with Refractory Lymphoma, Breast Cancer, or Other Advanced Cancer, with Crossover to TAX/IL-1A for Breast Cancer Patients (Summary Last Modified 11/93)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				NCI-92-C-0115C NCI-MB-279, NCI-T92-0017N, T92-0017

Last Modified: 4/23/2008


6.		Phase II Randomized Study to Evaluate the Hematopoietic Effect of IL-1A on Granulothrombocytopenia Associated with Hemibody Irradiation

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care, Treatment				Completed				18 and over				NCI				RTOG-9206 RTOG-92-06

Last Modified: 4/21/2008


7.		Phase I Study of IL-1A/MTX in Patients with Advanced Solid Tumors (Summary Last Modified 02/95)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				18 and over				NCI				BWH-92-5440-01 NCI-T93-0188O, T93-0188

Last Modified: 4/21/2008


8.		Phase I Study of IL-1A/CBDCA for Advanced Solid Tumors (Summary Last Modified 04/95)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				18 and over				NCI				BWH-92-5232-02 NCI-T93-0187O, T93-0187

Last Modified: 4/21/2008


9.		Phase I Study of IL-1A/DTIC in Patients with Solid Tumors (Summary Last Modified 05/95)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				18 and over				NCI				BWH-T92-0254 NCI-T92-0254O, T92-0254

Last Modified: 4/21/2008


10.		Phase I Study of IL-1A/CTX in Patients with Advanced Solid Tumors (Summary Last Modified 04/95)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				over 18				NCI				PCI-9341 NCI-T93-0135D, T93-0135

Select All on One Page


					1 2 3 Next >

| | | | | | | |

A Service of the National Cancer Institute